EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Statement Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ SATO PHARMACEUTICAL +
@ タキロン +
@ 小林製薬 +
@ TAIYO HOLDINGS +
@ Central Glass +
@ TAKASAGO INTERNATIONAL +
@ KANEKA +
@ 積水樹脂 +
@ SAKATA INX +
@ 参天製薬 +
@ Milbon +
@ T&K TOKA +
@ TOWA PHARMACEUTICAL +
@ ZEON +
@ Noevir Holdings +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Hitachi Zosen etc.
graph
NIPPON COKE & ENGINEERING
graph
Nissan Motor
graph
クラリオン
graph
クラリオン
graph

Financial Statement Details: KANEKA (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Statement data

U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 418 B
 *  Net: ¥ 249 B
 (Ratio: 59.63%)
[BS] 2010-03-31
 *  Total: ¥ 432 B
 *  Net: ¥ 257 B
 (Ratio: 59.41%)
[BS] 2011-03-31
 *  Total: ¥ 455 B
 *  Net: ¥ 261 B
 (Ratio: 57.53%)
[BS] 2012-03-31
 *  Total: ¥ 467 B
 *  Net: ¥ 257 B
 (Ratio: 55.12%)
[BS] 2013-03-31
 *  Total: ¥ 484 B
 *  Net: ¥ 270 B
 (Ratio: 55.83%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 24 B ¥ 41 B ¥ 37 B ¥ 27 B ¥ 32 B
Other Current Assets ¥ 168 B ¥ 166 B ¥ 184 B ¥ 208 B ¥ 210 B
Tangible Assets ¥ 162 B ¥ 161 B ¥ 163 B ¥ 164 B ¥ 169 B
Intangible Assets ¥ 2 B ¥ 1 B ¥ 7 B ¥ 6 B ¥ 8 B
Investment etc. ¥ 61 B ¥ 61 B ¥ 62 B ¥ 59 B ¥ 63 B
Total Assets ¥ 418 B ¥ 432 B ¥ 455 B ¥ 467 B ¥ 484 B
Current Liabilities ¥ 118 B ¥ 107 B ¥ 126 B ¥ 145 B ¥ 149 B
Fixed Liabilities ¥ 50 B ¥ 68 B ¥ 66 B ¥ 63 B ¥ 64 B
Capital stock ¥ 33 B ¥ 33 B ¥ 33 B ¥ 33 B ¥ 33 B
Capital surplus etc. ¥ 216 B ¥ 224 B ¥ 228 B ¥ 224 B ¥ 237 B
Liabilities and net assets ¥ 418 B ¥ 432 B ¥ 455 B ¥ 467 B ¥ 484 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 449 B
 *  Income: ¥ -1 B
 (Ratio: -0.41%)
[PL] 2010-03-31
 *  Sales: ¥ 412 B
 *  Income: ¥ 8 B
 (Ratio: 2.04%)
[PL] 2011-03-31
 *  Sales: ¥ 453 B
 *  Income: ¥ 11 B
 (Ratio: 2.56%)
[PL] 2012-03-31
 *  Sales: ¥ 469 B
 *  Income: ¥ 5 B
 (Ratio: 1.15%)
[PL] 2013-03-31
 *  Sales: ¥ 476 B
 *  Income: ¥ 9 B
 (Ratio: 1.96%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 449 B ¥ 412 B ¥ 453 B ¥ 469 B ¥ 476 B
Cost of Sales ¥ 353 B ¥ 310 B ¥ 339 B ¥ 359 B ¥ 359 B
Gross profit ¥ 96 B ¥ 102 B ¥ 114 B ¥ 109 B ¥ 116 B
Other income ¥ 3 B ¥ 3 B ¥ 3 B ¥ 7 B ¥ 4 B
SG&A ¥ 88 B ¥ 84 B ¥ 93 B ¥ 96 B ¥ 100 B
Other expenses ¥ 12 B ¥ 11 B ¥ 12 B ¥ 14 B ¥ 11 B
Net income ¥ -1 B ¥ 8 B ¥ 11 B ¥ 5 B ¥ 9 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Operating CF
  • Investment CF
  • Financial CF
  • Foreign Exchange Effects
  • Net Change in Cash
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
[CF] 2009-03-31
 *  OCF: ¥ 26 B
 *  Cash: ¥ +2 B
[CF] 2010-03-31
 *  OCF: ¥ 57 B
 *  Cash: ¥ +15 B
[CF] 2011-03-31
 *  OCF: ¥ 34 B
 *  Cash: ¥ -3 B
[CF] 2012-03-31
 *  OCF: ¥ 15 B
 *  Cash: ¥ -9 B
[CF] 2013-03-31
 *  OCF: ¥ 32 B
 *  Cash: ¥ +4 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Operating CF ¥ 26 B ¥ 57 B ¥ 34 B ¥ 15 B ¥ 32 B
Investment CF ¥ -36 B ¥ -25 B ¥ -34 B ¥ -28 B ¥ -32 B
Financial CF ¥ 12 B ¥ -16 B ¥ -4 B ¥ 2 B ¥ 3 B
Foreign Exchange Effects ¥ -171 M ¥ 200 M ¥ 807 M ¥ 369 M ¥ 713 M
Net Change in Cash ¥ 2 B ¥ 15 B ¥ -3 B ¥ -9 B ¥ 4 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ -1 B
 *  Net: ¥ -18 B
[SS] 2010-03-31
 *  Income: ¥ 8 B
 *  Net: ¥ +7 B
[SS] 2011-03-31
 *  Income: ¥ 11 B
 *  Net: ¥ +4 B
[SS] 2012-03-31
 *  Income: ¥ 5 B
 *  Net: ¥ -4 B
[SS] 2013-03-31
 *  Income: ¥ 9 B
 *  Net: ¥ +12 B
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Issuance of new shares - - - - -
Dividends from surplus ¥ -5 B ¥ -5 B ¥ -5 B ¥ -5 B ¥ -5 B
Net income ¥ -1 B ¥ 8 B ¥ 11 B ¥ 5 B ¥ 9 B
Purchase of treasury stock ¥ -581 M ¥ -20 M ¥ -168 M ¥ -806 M -
Other Change in Stockholders Equity ¥ 114 M ¥ -80 M ¥ 19 M ¥ -55 M ¥ -315 M
Other Change in Net Assets ¥ -11 B ¥ 4 B ¥ -1 B ¥ -3 B ¥ 9 B
Net Change in Net Assets ¥ -18 B ¥ 7 B ¥ 4 B ¥ -4 B ¥ 12 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Cash etc.
  • Other Current Assets
  • Tangible Assets
  • Intangible Assets
  • Investment etc.
  • Current Liabilities
  • Fixed Liabilities
  • Capital stock
  • Capital surplus etc.
*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
[BS] 2009-03-31
 *  Total: ¥ 347 B
 *  Net: ¥ 212 B
 (Ratio: 61.03%)
[BS] 2010-03-31
 *  Total: ¥ 353 B
 *  Net: ¥ 213 B
 (Ratio: 60.42%)
[BS] 2011-03-31
 *  Total: ¥ 359 B
 *  Net: ¥ 208 B
 (Ratio: 57.94%)
[BS] 2012-03-31
 *  Total: ¥ 362 B
 *  Net: ¥ 202 B
 (Ratio: 55.80%)
[BS] 2013-03-31
 *  Total: ¥ 369 B
 *  Net: ¥ 207 B
 (Ratio: 56.17%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash etc. ¥ 15 B ¥ 29 B ¥ 20 B ¥ 18 B -
Other Current Assets ¥ 124 B ¥ 123 B ¥ 132 B ¥ 147 B -
Tangible Assets ¥ 106 B ¥ 105 B ¥ 99 B ¥ 95 B -
Intangible Assets ¥ 1 B ¥ 1 B ¥ 1 B ¥ 1 B -
Investment etc. ¥ 100 B ¥ 93 B ¥ 105 B ¥ 99 B ¥ 369 B
Total Assets ¥ 347 B ¥ 353 B ¥ 359 B ¥ 362 B ¥ 369 B
Current Liabilities ¥ 90 B ¥ 81 B ¥ 97 B ¥ 110 B ¥ 161 B
Fixed Liabilities ¥ 44 B ¥ 58 B ¥ 53 B ¥ 49 B -
Capital stock ¥ 33 B ¥ 33 B ¥ 33 B ¥ 33 B -
Capital surplus etc. ¥ 179 B ¥ 180 B ¥ 175 B ¥ 169 B ¥ 207 B
Liabilities and net assets ¥ 347 B ¥ 353 B ¥ 359 B ¥ 362 B ¥ 369 B
U-Chart(pie chart)2009-03-312010-03-312011-03-312012-03-312013-03-31
  • Sales
  • Cost of Sales
  • Other income
  • SG&A
  • Other expenses
  • Net income
*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
[PL] 2009-03-31
 *  Sales: ¥ 272 B
 *  Income: ¥ -2 B
 (Ratio: -0.91%)
[PL] 2010-03-31
 *  Sales: ¥ 240 B
 *  Income: ¥ 3 B
 (Ratio: 1.40%)
[PL] 2011-03-31
 *  Sales: ¥ 257 B
 *  Income: ¥ 1 B
 (Ratio: 0.74%)
[PL] 2012-03-31
 *  Sales: ¥ 266 B
 *  Income: ¥ 2 B
 (Ratio: 0.75%)
[PL] 2013-03-31
 *  Sales: ¥ 268 B
 *  Income: ¥ 7 B
 (Ratio: 2.67%)
Financial Statement Details2009-03-312010-03-312011-03-312012-03-312013-03-31
Sales ¥ 272 B ¥ 240 B ¥ 257 B ¥ 266 B ¥ 268 B
Cost of Sales ¥ 215 B ¥ 185 B ¥ 200 B ¥ 208 B ¥ 261 B
Gross profit ¥ 56 B ¥ 54 B ¥ 57 B ¥ 58 B ¥ 7 B
Other income ¥ 4 B ¥ 5 B ¥ 3 B ¥ 9 B -
SG&A ¥ 54 B ¥ 51 B ¥ 54 B ¥ 57 B -
Other expenses ¥ 9 B ¥ 6 B ¥ 4 B ¥ 8 B -
Net income ¥ -2 B ¥ 3 B ¥ 1 B ¥ 2 B ¥ 7 B
U-Chart(pie chart)2009-03-312010-03-312011-03-31
  • Issuance of new shares
  • Dividends from surplus
  • Net income
  • Purchase of treasury stock
  • Other Change in Stockholders Equity
  • Other Change in Net Assets
  • Net Change in Net Assets
*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
[SS] 2009-03-31
 *  Income: ¥ -2 B
 *  Net: ¥ -14 B
[SS] 2010-03-31
 *  Income: ¥ 3 B
 *  Net: ¥ +1 B
[SS] 2011-03-31
 *  Income: ¥ 1 B
 *  Net: ¥ -5 B
Financial Statement Details2009-03-312010-03-312011-03-31
Issuance of new shares - - -
Dividends from surplus ¥ -5 B ¥ -5 B ¥ -5 B
Net income ¥ -2 B ¥ 3 B ¥ 1 B
Purchase of treasury stock ¥ -570 M ¥ -11 M ¥ -168 M
Other Change in Stockholders Equity - - ¥ 1 M
Other Change in Net Assets ¥ -5 B ¥ 3 B ¥ -1 B
Net Change in Net Assets ¥ -14 B ¥ 1 B ¥ -5 B

Consolidated :Balance sheet (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Net assets¥ 267 B¥ 249 B¥ 257 B¥ 261 B¥ 257 B¥ 270 B
   Cash and deposits¥ 20 B¥ 24 B¥ 41 B¥ 37 B¥ 27 B¥ 32 B
   Notes and accounts receivable-trade¥ 113 B¥ 86 B¥ 93 B¥ 103 B¥ 118 B¥ 116 B
    Short-term investment securities¥ 1 B¥ 422 M¥ 422 M¥ 322 M¥ 322 M¥ 110 M
    Merchandise and finished goods¥ 39 B¥ 34 B¥ 38 B¥ 44 B¥ 47 B
     Raw materials and supplies¥ 18 B¥ 19 B¥ 22 B¥ 23 B¥ 24 B
     Work in process¥ 10 B¥ 8 B¥ 8 B¥ 8 B¥ 8 B
   Deferred tax assets¥ 4 B¥ 4 B¥ 5 B¥ 6 B¥ 6 B¥ 5 B
    Allowance for doubtful accounts¥ -448 M¥ -391 M¥ -368 M¥ -400 M¥ -164 M¥ -110 M
   Other¥ 7 B¥ 9 B¥ 5 B¥ 6 B¥ 6 B¥ 8 B
   Current assets¥ 218 B¥ 192 B¥ 208 B¥ 222 B¥ 236 B¥ 242 B
     Buildings and structures, net¥ 51 B¥ 51 B¥ 51 B¥ 53 B¥ 52 B¥ 53 B
     Machinery, equipment and vehicles, net¥ 68 B¥ 65 B¥ 65 B¥ 64 B¥ 62 B¥ 64 B
    Land¥ 22 B¥ 27 B¥ 28 B¥ 30 B¥ 29 B¥ 28 B
    Construction in progress¥ 13 B¥ 13 B¥ 12 B¥ 9 B¥ 15 B¥ 17 B
      Other, net¥ 3 B¥ 4 B¥ 3 B¥ 4 B¥ 4 B¥ 4 B
    Property, plant and equipment¥ 160 B¥ 162 B¥ 161 B¥ 163 B¥ 164 B¥ 169 B
    Goodwill¥ 4 B¥ 3 B¥ 4 B
     Other¥ 1 B¥ 2 B¥ 3 B¥ 4 B
    Intangible assets¥ 2 B¥ 2 B¥ 1 B¥ 7 B¥ 6 B¥ 8 B
     Investment securities¥ 53 B¥ 39 B¥ 46 B¥ 46 B¥ 41 B¥ 46 B
     Investments in capital¥ 586 M¥ 743 M¥ 664 M¥ 931 M¥ 1 B¥ 1 B
     Long-term loans receivable¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
     Long-term prepaid expenses¥ 1 B¥ 2 B¥ 1 B¥ 2 B¥ 1 B¥ 1 B
     Deferred tax assets¥ 4 B¥ 9 B¥ 5 B¥ 5 B¥ 6 B¥ 3 B
     Other¥ 9 B¥ 8 B¥ 6 B¥ 6 B¥ 7 B¥ 9 B
      Allowance for doubtful accounts¥ -298 M¥ -327 M¥ -320 M¥ -568 M¥ -527 M¥ -226 M
    Investments and other assets¥ 70 B¥ 61 B¥ 61 B¥ 62 B¥ 59 B¥ 63 B
   Noncurrent assets¥ 234 B¥ 226 B¥ 224 B¥ 232 B¥ 231 B¥ 241 B
  Assets¥ 452 B¥ 418 B¥ 432 B¥ 455 B¥ 467 B¥ 484 B
   Notes and accounts payable-trade¥ 67 B¥ 43 B¥ 53 B¥ 60 B¥ 64 B¥ 64 B
   Accrued expenses¥ 8 B¥ 7 B¥ 8 B¥ 8 B¥ 9 B¥ 9 B
    Provision for directors' bonuses¥ 107 M¥ 72 M¥ 99 M¥ 117 M¥ 106 M¥ 115 M
    Accounts payable-other¥ 22 B¥ 17 B¥ 18 B¥ 22 B¥ 28 B¥ 21 B
    Income taxes payable¥ 4 B¥ 1 B¥ 3 B¥ 4 B¥ 2 B¥ 1 B
    Accrued consumption taxes¥ 817 M¥ 602 M¥ 1 B¥ 496 M¥ 358 M¥ 614 M
    Short-term loans payable¥ 22 B¥ 40 B¥ 19 B¥ 21 B¥ 37 B¥ 48 B
   Other¥ 7 B¥ 7 B¥ 2 B¥ 2 B¥ 2 B¥ 3 B
   Current liabilities¥ 134 B¥ 118 B¥ 107 B¥ 126 B¥ 145 B¥ 149 B
    Bonds payable¥ 10 B¥ 5 B¥ 20 B¥ 15 B¥ 15 B¥ 15 B
    Long-term loans payable¥ 17 B¥ 22 B¥ 24 B¥ 26 B¥ 24 B¥ 25 B
    Provision for retirement benefits¥ 18 B¥ 18 B¥ 19 B¥ 19 B¥ 19 B¥ 19 B
    Provision for directors' retirement benefits¥ 234 M¥ 265 M¥ 283 M¥ 320 M¥ 336 M¥ 322 M
   Negative goodwill¥ 847 M¥ 639 M¥ 430 M¥ 208 M
    Deferred tax liabilities¥ 1 B¥ 444 M¥ 333 M¥ 1 B¥ 1 B¥ 873 M
    Other¥ 3 B¥ 3 B¥ 3 B¥ 4 B¥ 3 B¥ 3 B
   Noncurrent liabilities¥ 50 B¥ 50 B¥ 68 B¥ 66 B¥ 63 B¥ 64 B
  Liabilities¥ 185 B¥ 168 B¥ 175 B¥ 193 B¥ 209 B¥ 214 B
   Capital stock¥ 33 B¥ 33 B¥ 33 B¥ 33 B¥ 33 B¥ 33 B
    Capital surplus¥ 34 B¥ 34 B¥ 34 B¥ 34 B¥ 34 B¥ 34 B
    Retained earnings¥ 194 B¥ 188 B¥ 191 B¥ 197 B¥ 197 B¥ 200 B
   Treasury stock¥ -9 B¥ -9 B¥ -9 B¥ -9 B¥ -10 B¥ -10 B
   Shareholders' equity¥ 253 B¥ 246 B¥ 249 B¥ 255 B¥ 254 B¥ 258 B
   Valuation difference on available-for-sale securities¥ 10 B¥ 4 B¥ 8 B¥ 6 B¥ 4 B¥ 8 B
   Foreign currency translation adjustment¥ -2 B¥ -7 B¥ -8 B¥ -10 B¥ -11 B¥ -5 B
   Valuation and translation adjustments¥ 7 B¥ -3 B¥ -142 M¥ -3 B¥ -7 B¥ 2 B
  Subscription rights to shares¥ 50 M¥ 75 M¥ 109 M¥ 127 M¥ 137 M¥ 159 M
  Minority interests¥ 6 B¥ 6 B¥ 7 B¥ 9 B¥ 9 B¥ 9 B
 Liabilities and net assets¥ 452 B¥ 418 B¥ 432 B¥ 455 B¥ 467 B¥ 484 B
    Current portion of bonds¥ 5 B-
   Deferred gains or losses on hedges¥ 3 M¥ 1 M
   Inventories¥ 71 B
Consolidated :Income statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
   Net sales¥ 502 B¥ 449 B¥ 412 B¥ 453 B¥ 469 B¥ 476 B
 Operating income¥ 35 B¥ 7 B¥ 17 B¥ 21 B¥ 13 B¥ 15 B
 Ordinary income¥ 33 B¥ 5 B¥ 16 B¥ 20 B¥ 12 B¥ 16 B
 Net income¥ 18 B¥ -1 B¥ 8 B¥ 11 B¥ 5 B¥ 9 B
 Comprehensive income¥ 9 B¥ 2 B¥ 19 B
   Cost of sales¥ 376 B¥ 353 B¥ 310 B¥ 339 B¥ 359 B¥ 359 B
    Selling, general and administrative expenses¥ 91 B¥ 88 B¥ 84 B¥ 93 B¥ 96 B¥ 100 B
 Gross profit¥ 126 B¥ 96 B¥ 102 B¥ 114 B¥ 109 B¥ 116 B
  Interest income¥ 307 M¥ 253 M¥ 146 M¥ 121 M¥ 116 M¥ 63 M
  Dividends income¥ 1 B¥ 1 B¥ 1 B¥ 995 M¥ 1 B¥ 1 B
  Amortization of negative goodwill¥ 341 M¥ 249 M¥ 236 M¥ 348 M
  Equity in earnings of affiliates¥ 60 M¥ 168 M¥ 1 B¥ 383 M¥ 55 M
  Foreign exchange gains¥ 30 M¥ 205 M¥ 114 M¥ 888 M¥ 2 B
  Other¥ 545 M¥ 932 M¥ 768 M¥ 835 M¥ 880 M¥ 938 M
  Non-operating income¥ 3 B¥ 3 B¥ 2 B¥ 3 B¥ 4 B¥ 4 B
  Interest expenses¥ 1 B¥ 1 B¥ 928 M¥ 892 M¥ 885 M¥ 890 M
  Loss on retirement of noncurrent assets¥ 1 B¥ 908 M¥ 1 B¥ 1 B¥ 1 B¥ 1 B
  Compensation expenses¥ 85 M¥ 637 M-
  Other¥ 1 B¥ 2 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
  Non-operating expenses¥ 5 B¥ 5 B¥ 4 B¥ 3 B¥ 4 B¥ 4 B
  Gain on sales of noncurrent assets¥ 189 M¥ 172 M-
  Gain on sales of investment securities-¥ 2 B¥ 277 M
  Extraordinary income¥ 189 M¥ 192 M¥ 3 B¥ 277 M
  Loss on sales of noncurrent assets-¥ 243 M-
  Business structure improvement expenses-¥ 2 B-
  Extraordinary loss¥ 2 B¥ 6 B¥ 1 B¥ 1 B¥ 4 B¥ 1 B
 Income before income taxes¥ 31 B¥ -754 M¥ 15 B¥ 19 B¥ 11 B¥ 14 B
 Income taxes¥ 11 B¥ 888 M¥ 5 B¥ 6 B¥ 5 B¥ 5 B
  Income taxes-current¥ 11 B¥ 3 B¥ 4 B¥ 6 B¥ 5 B¥ 3 B
  Income taxes-deferred¥ 627 M¥ -2 B¥ 1 B¥ -36 M¥ 381 M¥ 2 B
 Income before minority interests¥ 12 B¥ 5 B¥ 9 B
 Minority interests in income¥ 476 M¥ 208 M¥ 899 M¥ 1 B¥ 475 M¥ 151 M
  Valuation difference on available-for-sale securities¥ -1 B¥ -2 B¥ 3 B
  Foreign currency translation adjustment¥ -1 B¥ -1 B¥ 6 B
  Share of other comprehensive income of associates accounted for using equity method¥ -9 M¥ -2 M¥ 20 M
  Other comprehensive income¥ -3 B¥ -3 B¥ 9 B
   Comprehensive income attributable to owners of the parent¥ 8 B¥ 1 B¥ 18 B
   Comprehensive income attributable to minority interests¥ 951 M¥ 364 M¥ 346 M
  Gain on negative goodwill¥ 192 M-
  Loss on disaster¥ 1 B-
  Loss on valuation of investment securities¥ 4 B¥ 518 M-
  Gain on sales of investment securities¥ 940 M¥ 849 M¥ 240 M¥ 3 M
  Non-recurring depreciation on noncurrent assets¥ 671 M
  Equity in losses of affiliates¥ 489 M
  Impairment loss¥ 1 B¥ 1 B
  Loss on liquidation of business¥ 1 B¥ 924 M
  Foreign exchange losses¥ 412 M
Consolidated :Cash flow statement (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
  Subtotal¥ 52 B¥ 34 B¥ 58 B¥ 40 B¥ 21 B¥ 37 B
   Depreciation and amortization¥ 24 B¥ 27 B¥ 26 B¥ 28 B¥ 29 B¥ 29 B
   Increase (decrease) in allowance for doubtful accounts¥ 95 M¥ -24 M¥ -29 M¥ 279 M¥ -271 M¥ -356 M
   Interest and dividends income¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
   Interest expenses¥ 1 B¥ 1 B¥ 928 M¥ 892 M¥ 885 M¥ 890 M
   Equity in (earnings) losses of affiliates¥ -60 M¥ 489 M¥ -168 M¥ -1 B¥ -383 M¥ -55 M
   Decrease (increase) in notes and accounts receivable-trade¥ 4 B¥ 24 B¥ -6 B¥ -8 B¥ -15 B¥ 3 B
   Decrease (increase) in inventories¥ -7 B¥ 1 B¥ 5 B¥ -5 B¥ -9 B¥ -3 B
   Increase (decrease) in notes and accounts payable-trade¥ -321 M¥ -23 B¥ 9 B¥ 6 B¥ 3 B¥ -1 B
   Loss (gain) on sales of investment securities-¥ -2 B¥ -277 M
   Increase (decrease) in provision for retirement benefits¥ -1 B¥ 5 M¥ 3 B¥ -156 M¥ -290 M¥ 259 M
   Loss (gain) on disposal of noncurrent assets¥ 769 M¥ 2 B¥ 1 B¥ 855 M¥ 1 B¥ 767 M
   Other, net¥ -1 B¥ -4 B¥ 2 B¥ 65 M¥ 4 B¥ -5 B
  Interest and dividends income received¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B¥ 1 B
  Interest expenses paid¥ -1 B¥ -1 B¥ -932 M¥ -883 M¥ -883 M¥ -900 M
  Income taxes paid¥ -13 B¥ -7 B¥ -1 B¥ -5 B¥ -6 B¥ -5 B
  Net cash provided by (used in) operating activities¥ 39 B¥ 26 B¥ 57 B¥ 34 B¥ 15 B¥ 32 B
  Purchase of property, plant and equipment¥ -32 B¥ -35 B¥ -23 B¥ -26 B¥ -30 B¥ -31 B
  Proceeds from sales of property, plant and equipment¥ 189 M¥ 929 M¥ 613 M
  Purchase of investment securities¥ -2 B¥ -4 B¥ -1 B¥ -1 B¥ -201 M¥ -295 M
  Payments of loans receivable¥ -66 M¥ -198 M¥ -265 M¥ -637 M¥ -496 M¥ -792 M
  Collection of loans receivable¥ 300 M¥ 96 M¥ 205 M¥ 96 M¥ 391 M¥ 1 B
  Purchase of intangible assets¥ -684 M¥ -969 M¥ -379 M¥ -1 B¥ -1 B¥ -2 B
  Purchase of stocks of subsidiaries and affiliates¥ -761 M¥ -462 M¥ -1 B¥ -944 M¥ -112 M
  Proceeds from sales of stocks of subsidiaries and affiliates¥ 550 M¥ 479 M¥ 108 M¥ 174 M-
  Other, net¥ -532 M¥ 75 M¥ -779 M¥ -220 M¥ 187 M¥ -83 M
  Net cash provided by (used in) investing activities¥ -34 B¥ -36 B¥ -25 B¥ -34 B¥ -28 B¥ -32 B
  Proceeds from long-term loans payable¥ 867 M¥ 5 B¥ 2 B¥ 4 B¥ 5 B¥ 9 B
  Repayment of long-term loans payable¥ -1 B¥ -836 M¥ -2 B¥ -3 B¥ -2 B¥ -7 B
  Redemption of bonds¥ -5 B¥ -5 B¥ -5 B-
  Purchase of treasury stock¥ -1 B¥ -605 M¥ -25 M¥ -107 M¥ -836 M¥ -6 M
  Cash dividends paid¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B
  Net increase (decrease) in short-term loans payable¥ 3 B¥ 18 B¥ -21 B¥ 825 M¥ 10 B¥ 8 B
  Cash dividends paid to minority shareholders¥ -210 M¥ -119 M¥ -240 M¥ -158 M¥ -123 M¥ -302 M
  Repayments of lease obligations¥ -543 M¥ -429 M¥ -536 M¥ -421 M¥ -413 M
  Proceeds from sales of treasury stock¥ 9 M¥ 29 M¥ 2 M¥ 3 M¥ 1 M-
  Net cash provided by (used in) financing activities¥ -4 B¥ 12 B¥ -16 B¥ -4 B¥ 2 B¥ 3 B
 Effect of exchange rate change on cash and cash equivalents¥ -643 M¥ -171 M¥ 200 M¥ 807 M¥ 369 M¥ 713 M
 Net increase (decrease) in cash and cash equivalents¥ -647 M¥ 2 B¥ 15 B¥ -3 B¥ -9 B¥ 4 B
 Increase (decrease) in cash and cash equivalents resulting from change of scope of consolidation¥ 1 B-¥ 268 M
 Cash and cash equivalents¥ 21 B¥ 24 B¥ 40 B¥ 36 B¥ 27 B¥ 31 B
   Loss (gain) on valuation of investment securities¥ 4 B¥ 518 M-
  Purchase of investments in subsidiaries resulting in change in scope of consolidation¥ -4 B-
  Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation¥ 219 M-
   Non-recurring depreciation on noncurrent assets¥ 671 M
  Proceeds from issuance of bonds¥ 15 B
   Impairment loss¥ 1 B¥ 1 B
   Loss on liquidation of business¥ 1 B¥ 924 M
  Proceeds from stock issuance to minority shareholders¥ 36 M
Consolidated :Shareowners' equity (Annual ) 2008-03-312009-03-312010-03-312011-03-312012-03-312013-03-31
    Total changes of items during the period--
     Total changes of items during the period¥ -20 M--
     Dividends from surplus¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B
     Change of scope of consolidation-¥ -271 M
     Disposal of treasury stock¥ -14 M¥ -4 M¥ -6 M¥ -12 M¥ -5 M
     Total changes of items during the period¥ 6 B¥ -7 B¥ 2 B¥ 6 B¥ -89 M¥ 3 B
    Purchase of treasury stock¥ -1 B¥ -616 M¥ -34 M¥ -187 M¥ -836 M¥ -5 M
    Disposal of treasury stock¥ 10 M¥ 49 M¥ 19 M¥ 26 M¥ 43 M¥ 10 M
    Total changes of items during the period¥ 5 B¥ -566 M¥ -15 M¥ -161 M¥ -792 M¥ 5 M
    Dividends from surplus¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B
    Net income¥ 18 B¥ -1 B¥ 8 B¥ 11 B¥ 5 B¥ 9 B
    Purchase of treasury stock¥ -1 B¥ -616 M¥ -34 M¥ -187 M¥ -836 M¥ -5 M
    Disposal of treasury stock¥ 9 M¥ 35 M¥ 14 M¥ 19 M¥ 30 M¥ 5 M
    Change of scope of consolidation-¥ -271 M
    Total changes of items during the period¥ 11 B¥ -7 B¥ 2 B¥ 6 B¥ -882 M¥ 3 B
    Net changes of items other than shareholders' equity¥ -13 B¥ -5 B¥ 3 B¥ -1 B¥ -2 B¥ 3 B
    Total changes of items during the period¥ -13 B¥ -5 B¥ 3 B¥ -1 B¥ -2 B¥ 3 B
    Net changes of items other than shareholders' equity¥ -2 B¥ -5 B¥ -292 M¥ -1 B¥ -1 B¥ 5 B
    Total changes of items during the period¥ -2 B¥ -5 B¥ -292 M¥ -1 B¥ -1 B¥ 5 B
    Net changes of items other than shareholders' equity¥ -15 B¥ -11 B¥ 3 B¥ -3 B¥ -3 B¥ 9 B
    Total changes of items during the period¥ -15 B¥ -11 B¥ 3 B¥ -3 B¥ -3 B¥ 9 B
   Net changes of items other than shareholders' equity¥ 50 M¥ 25 M¥ 33 M¥ 17 M¥ 10 M¥ 22 M
   Total changes of items during the period¥ 50 M¥ 25 M¥ 33 M¥ 17 M¥ 10 M¥ 22 M
   Net changes of items other than shareholders' equity¥ 136 M¥ -137 M¥ 1 B¥ 1 B¥ 209 M¥ -100 M
   Total changes of items during the period¥ 136 M¥ -137 M¥ 1 B¥ 1 B¥ 209 M¥ -100 M
   Dividends from surplus¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B¥ -5 B
   Net income¥ 18 B¥ -1 B¥ 8 B¥ 11 B¥ 5 B¥ 9 B
   Purchase of treasury stock¥ -1 B¥ -616 M¥ -34 M¥ -187 M¥ -836 M¥ -5 M
   Disposal of treasury stock¥ 9 M¥ 35 M¥ 14 M¥ 19 M¥ 30 M¥ 5 M
   Change of scope of consolidation-¥ -271 M
   Net changes of items other than shareholders' equity¥ -15 B¥ -11 B¥ 4 B¥ -1 B¥ -3 B¥ 9 B
   Total changes of items during the period¥ -3 B¥ -18 B¥ 7 B¥ 4 B¥ -4 B¥ 12 B
    Net changes of items other than shareholders' equity¥ 3 M¥ -2 M¥ -1 M
    Total changes of items during the period¥ 3 M¥ -2 M¥ -1 M
     Disposal of treasury stock-
     Retirement of treasury stock¥ -20 M
     Retirement of treasury stock¥ -7 B
    Retirement of treasury stock¥ 7 B
    Retirement of treasury stock
   Retirement of treasury stock

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link


Ticker Market Industry Month report Rating
@ KANEKA 4118 TSE 1st Chemicals 3 Annual BBB

Related Company

@ NITTO FC (Sales ¥ 18 B) +
@ 積水樹脂 (Sales ¥ 64 B) +
@ TOYO INK SC HOLDINGS (Sales ¥ 248 B) +
@ TENMA (Sales ¥ 58 B) +
@ TOAGOSEI CO (Sales ¥ 148 B) +
@ 栄研化学 (Sales ¥ 28 B) +
@ Dr.Ci:Labo (Sales ¥ 33 B) +
@ Sumitomo Bakelite (Sales ¥ 183 B) +
@ Milbon (Sales ¥ 23 B) +
@ SATO PHARMACEUTICAL (Sales ¥ 38 B) +
@ TOWA PHARMACEUTICAL (Sales ¥ 55 B) +
@ T&K TOKA (Sales ¥ 53 B) +
@ 日油 (Sales ¥ 148 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.140 sec.)